We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Study Will Try to Prevent Asthma in Children

By HospiMedica staff writers
Posted on 18 Sep 2001
Six U.S. More...
medical centers will take part in a major two-year study that will attempt to prevent asthma in children at high risk for the disease. By treating airway inflammation at the earliest stages, researchers hope to prevent the permanent airway changes that lead to chronic asthma. The name of the study is PEAK (Prevention of Early Asthma in Kids).

In the study, researchers will enroll children of two to four years old who have had wheezing episodes in the previous year and who have one additional risk factor, such as eczema, allergies, or a parent with asthma. The children will be treated with the inhaled steroid fluticasone or an inactive inhaler as placebo twice daily for two years. Afterward, the children will be observed for one year to see if they develop asthma symptoms.

About 75% of asthmatics first develop the disease in childhood. The cause is unknown. Scientists believe a genetic predisposition coupled with environmental exposures first causes inflammation, which then progresses into chronic asthma. Steroids have been shown to be a safe, effective treatment for asthma symptoms in children as young as one year of age. Studies in older children, however, show that steroids seem to have little effect on the natural course of the disease, so that asthma symptoms return when steroids are discontinued. Other studies have suggested that irreversible changes in the airways occur in the very early stages and establish the long-term course of the disease. The PEAK researchers will try to prevent these irreversible changes.

"It is much easier to stop a small snowball that has been rolling for a few inches than it is to stop a much larger one that has been rolling for 100 yards,” said Joseph Spahn, M.D., co-investigator at National Jewish Medical and Research Center (Denver, CO, USA), one of the participating medical centers. "By treating the earliest stages of inflammation, we hope to stop the snowball of asthma before it gets a chance to gain momentum.”




Related Links:
National Jewish Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
New
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.